Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NYSE:OPK)

16.37
Delayed Data
As of Jul 31
 -0.01 / -0.06%
Today’s Change
8.02
Today|||52-Week Range
19.20
+63.86%
Year-to-Date
No recent news for OPKO Health Inc.

Today’s Trading

Previous close16.38
Today’s open16.50
Day’s range16.28 - 16.52
Volume2,674,236
Average volume (3 months)4,683,456
Market cap$7.8B
Dividend yield--
Data as of 4:04pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-28.12%
Earnings growth (this year)+43.09%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.60%
P/E ratioNM
Price/Sales46.27
Price/Book8.64

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+6.57+4.04%
MDVNMedivation Inc+8.36+8.62%
RCPTReceptos Inc+0.38+0.17%
ANACAnacor Pharmaceutica...+0.49+0.33%
Data as of 4:14pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$91.1M
Annual profit (last year)-$171.7M
Net profit margin-188.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts